 |
|
|
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
|
| |
American
Biogenetic Sciences researches and develops diagnostic
tests for cardiac conditions and infectious diseases,
as well as new treatments
for neurological disorders including epilepsy, migraine,
mania, Parkinson's, male impotence treatment and Alzheimer's disease. ABS also
seeks out new technologies and conducts research and
development throughout its Global
Scientific Network, in the U.S., Europe, Israel,
Russia and China. The company's enabling technology
includes a patented Antigen-Free
mouse colony which allows for the generation of
highly specific monoclonal antibodies (Mabs), not acquirable
from conventional systems. |
|
|
|
|
|
|
|
|
American Biogenetic Sciences, Inc. ©2000 |
|
